[go: up one dir, main page]

IL162350A0 - Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives - Google Patents

Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives

Info

Publication number
IL162350A0
IL162350A0 IL16235002A IL16235002A IL162350A0 IL 162350 A0 IL162350 A0 IL 162350A0 IL 16235002 A IL16235002 A IL 16235002A IL 16235002 A IL16235002 A IL 16235002A IL 162350 A0 IL162350 A0 IL 162350A0
Authority
IL
Israel
Prior art keywords
büfuran
dibenzo
tetrahydro
cis
fused
Prior art date
Application number
IL16235002A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL162350A0 publication Critical patent/IL162350A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL16235002A 2001-12-07 2002-12-02 Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives IL162350A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204962 2001-12-07
PCT/EP2002/013561 WO2003048147A2 (fr) 2001-12-07 2002-12-02 Preparation de derives de 3,3a,8,12b-tetrahydro-2$i(h)-dibenzo[3,4:6,7]cyclohepta[1,2-b]furanes fusionnes en cis

Publications (1)

Publication Number Publication Date
IL162350A0 true IL162350A0 (en) 2005-11-20

Family

ID=8181461

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16235002A IL162350A0 (en) 2001-12-07 2002-12-02 Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives

Country Status (16)

Country Link
US (1) US7205335B2 (fr)
EP (1) EP1463722A2 (fr)
JP (1) JP2005511692A (fr)
KR (1) KR20050044334A (fr)
CN (1) CN1697833A (fr)
AU (1) AU2002352205A1 (fr)
BR (1) BR0214775A (fr)
CA (1) CA2468040A1 (fr)
HR (1) HRP20040489A2 (fr)
HU (1) HUP0402325A2 (fr)
IL (1) IL162350A0 (fr)
MX (1) MXPA04005399A (fr)
NO (1) NO20042883L (fr)
PL (1) PL370440A1 (fr)
WO (1) WO2003048147A2 (fr)
ZA (1) ZA200404392B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003048146A1 (fr) * 2001-12-07 2003-06-12 Janssen Pharmaceutica N.V. Preparation de derives de 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furane a fusion trans
US7470809B2 (en) * 2004-08-31 2008-12-30 Janssen Pharmaceutica N.V. Process for the production of [2-(4-fluoro-benzyl)-phenyl]-acetic acid
CA2588760C (fr) 2004-12-07 2014-05-13 Janssen Pharmaceutica N.V. Derives substitues de tetrahydropyrane tetracyclique, de pyrrolidine et de tetrahydrothiophene
MX2007016247A (es) 2005-06-17 2008-03-10 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos novedosos que contienen una cadena lateral de amida ciclica.
PT2874607T (pt) 2012-07-17 2017-08-14 Dow Global Technologies Llc Resumo
KR102220604B1 (ko) * 2012-07-17 2021-03-02 다우 글로벌 테크놀로지스 엘엘씨 유기 액체 희석제 및 매우 낮은 점도의 셀룰로즈 에테르를 포함하는 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA001002B1 (ru) 1996-04-12 2000-08-28 Жансен Фармасетика Н.В. Замещенные тетрациклические производные тетрагидрофурана
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі

Also Published As

Publication number Publication date
AU2002352205A1 (en) 2003-06-17
MXPA04005399A (es) 2004-10-11
US7205335B2 (en) 2007-04-17
EP1463722A2 (fr) 2004-10-06
CA2468040A1 (fr) 2003-06-12
HUP0402325A2 (hu) 2005-02-28
US20050033067A1 (en) 2005-02-10
PL370440A1 (en) 2005-05-30
ZA200404392B (en) 2005-09-27
NO20042883L (no) 2004-07-07
CN1697833A (zh) 2005-11-16
WO2003048147A3 (fr) 2004-04-01
KR20050044334A (ko) 2005-05-12
BR0214775A (pt) 2004-11-09
JP2005511692A (ja) 2005-04-28
WO2003048147A2 (fr) 2003-06-12
HRP20040489A2 (en) 2005-04-30

Similar Documents

Publication Publication Date Title
AU2002361992A1 (en) 1,4-dihydro-1,4-diphenylpyridine derivatives
IL160708A0 (en) 1, 6-naphthyridine derivatives as antidiabetics
IL160081A0 (en) Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
IL161881A (en) N,n'-substituted-1,3-diamino-2- hydroxypropane derivatives
IL158784A0 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
IL157704A0 (en) 4,5-dihydro-1h-pyrazole derivatives having potent cbi-antagonistic activity
IL153508A0 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
ZA200203252B (en) Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AP2004002981A0 (en) Method for the preparation of hexahydro-furo [2,3-B]furan-3-o1.
MXPA03008140A (es) Amidas de acido benzofuran-2-carboxilico sustituidas.
AU2002367323A1 (en) Benzothieno (3,2-
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
PL367179A1 (en) 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds
ZA200109206B (en) Preparation of substituted piperidin-4-ones.
IL162188A0 (en) Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives
AU2002303529A1 (en) Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
IL162350A0 (en) Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
MXPA03008394A (es) Derivados de biuretano.
MXPA03009209A (es) Formulaciones de 3,7-diazabiciclo-[3.3.1] como compuestos anti-arritmicos.
MXPA03009210A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
AU2002233181A1 (en) Novel, 2,5-diazabicyclo[2.2.1]heptane derivatives
EG23305A (en) Preparation of 1,2-dicloroethane.